Follow
Roel Bakker
Roel Bakker
modeller of infectious disease dynamics, London School of Hygiene and Tropical Medicine
Verified email at lshtm.ac.uk
Title
Cited by
Cited by
Year
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
2442014
The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa
JAC Hontelez, SJ de Vlas, R Baltussen, ML Newell, R Bakker, F Tanser, ...
Aids 26, S19-S30, 2012
1992012
Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention …
EL Korenromp, RG White, KK Orroth, R Bakker, A Kamali, D Serwadda, ...
The Journal of infectious diseases 191 (Supplement_1), S168-S178, 2005
1832005
Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study
JAC Hontelez, MN Lurie, T Bärnighausen, R Bakker, R Baltussen, ...
PLoS medicine 10 (10), e1001534, 2013
1632013
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan …
EE Freeman, KK Orroth, RG White, JR Glynn, R Bakker, MC Boily, ...
Sexually transmitted infections 83 (suppl 1), i17-i24, 2007
1492007
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when?
RG White, JR Glynn, KK Orroth, EE Freeman, R Bakker, HA Weiss, ...
Aids 22 (14), 1841-1850, 2008
1222008
Ageing with HIV in south africa
JAC Hontelez, MN Lurie, ML Newell, R Bakker, F Tanser, T Bärnighausen, ...
Aids 25 (13), 1665-1667, 2011
1142011
Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study
RG White, KK Orroth, EL Korenromp, R Bakker, M Wambura, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 37 (4), 1500-1513, 2004
1102004
Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study
KK Orroth, EE Freeman, R Bakker, A Buvé, JR Glynn, MC Boily, RG White, ...
Sexually transmitted infections 83 (suppl 1), i5-i16, 2007
1092007
Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment
LE Coffeng, WA Stolk, A Hoerauf, D Habbema, R Bakker, AD Hopkins, ...
PloS one 9 (12), e115886, 2014
892014
Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy?
RG White, KK Orroth, JR Glynn, EE Freeman, R Bakker, JDF Habbema, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 47 (3), 346-353, 2008
882008
Concerted efforts to control or eliminate neglected tropical diseases: how much health will be gained?
SJ de Vlas, WA Stolk, EA le Rutte, JAC Hontelez, R Bakker, DJ Blok, ...
PLoS neglected tropical diseases 10 (2), e0004386, 2016
802016
HIV dynamics and behaviour change as determinants of the impact of sexually transmitted disease treatment on HIV transmission in the context of the Rakai trial
EL Korenromp, R Bakker, SJ Vlas, RH Gray, MJ Wawer, D Serwadda, ...
Aids 16 (16), 2209-2218, 2002
792002
The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa
JAC Hontelez, SJ De Vlas, F Tanser, R Bakker, T Bärnighausen, ...
PloS one 6 (7), e21919, 2011
772011
Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa
EE Freeman, RG White, R Bakker, KK Orroth, HA Weiss, A Buvé, ...
Vaccine 27 (6), 940-946, 2009
672009
cAMP-mediated effects of ouabain and theophylline on paracellular ion selectivity
R Bakker, JA Groot
American Journal of Physiology-Gastrointestinal and Liver Physiology 246 (2 …, 1984
641984
Feasibility of controlling hookworm infection through preventive chemotherapy: a simulation study using the individual-based WORMSIM modelling framework
LE Coffeng, R Bakker, A Montresor, SJ de Vlas
Parasites & vectors 8, 1-16, 2015
612015
Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually …
KK Orroth, RG White, EL Korenromp, R Bakker, J Changalucha, ...
Sexually transmitted diseases 33 (9), 536-544, 2006
592006
Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management …
EJ Lenk, WK Redekop, M Luyendijk, C Fitzpatrick, L Niessen, WA Stolk, ...
PLoS neglected tropical diseases 12 (3), e0006250, 2018
542018
The socioeconomic benefit to individuals of achieving the 2020 targets for five preventive chemotherapy neglected tropical diseases
WK Redekop, EJ Lenk, M Luyendijk, C Fitzpatrick, L Niessen, WA Stolk, ...
PLoS neglected tropical diseases 11 (1), e0005289, 2017
532017
The system can't perform the operation now. Try again later.
Articles 1–20